Created by and for people with chronic pain, the NFMCPA believes our united voices:
- educate policy makers and medical professionals;
- generate supportive attitudes; and
- change the way we receive health care.
TWO ISSUES ARE OF GREAT CONCERN!
#1 Last week, an FDA panel recommended changes for much stricter hydrocodone product* prescribing by changing them from Schedule III to Schedule II classification of drugs. No Physician's Assistants nor Nurse Practitioners would be licensed to prescribe these medications, making it difficult for people in chronic pain (especially in rural areas) to receive and fill pain prescriptions. The change would stop doctors from writing prescriptions for more than one month's supply at a time or calling in new prescriptions without seeing their patients.
#2 The group Physicians for Responsible Opioid Prescribing (PROP) sent a letter (in July 2012) to the FDA requesting they set regulations and caps on opioid analgesics for chronic non-cancer pain. (Those include all oxycodone medications AND hydrocodone medications if they are changed to Schedule II.) Click here for full letter.
- to a maximum daily dose--equivalent to 100 milligrams for non-cancer pain; and
- a maximum duration of 90-days for continuous daily use
Now it is very important that YOU–a chronic pain patient,
and your loved ones who are also affected by your pain condition--
VOICE YOUR OPINION!
Jan Favero Chambers
Founder and President
National Fibromyalgia & Chronic Pain Association